Successful retreatment with erlotinib after erlotinib-related interstitial lung disease.
Haci M TurkMustafa AdliMelih SimsekAltay AliyevMehmet BesirogluPublished in: Tumori (2021)
Incidence of interstitial lung disease is higher in men, smokers, and patients with pulmonary fibrosis. Interstitial lung disease radiologically causes ground-glass opacity and consolidation. The physician should quickly evaluate new respiratory symptoms in patients treated with epidermal growth factor receptor tyrosine kinase inhibitors, discontinue the epidermal growth factor receptor tyrosine kinase inhibitor treatment, and initiate corticosteroids if clinical diagnosis is interstitial lung disease.
Keyphrases
- interstitial lung disease
- epidermal growth factor receptor
- systemic sclerosis
- advanced non small cell lung cancer
- tyrosine kinase
- rheumatoid arthritis
- idiopathic pulmonary fibrosis
- pulmonary fibrosis
- emergency department
- primary care
- middle aged
- smoking cessation
- physical activity
- depressive symptoms
- combination therapy